🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06523751
Recruiting Not applicable

Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy

NCT06523751 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2023-06-13
Last updated
2025-04-03

Condition(s) studied

Open Angle GlaucomaPseudoexfoliation Glaucoma

Investigational drug(s) / intervention(s)

Trabeculopuncture

Trabeculopuncture: Trabeculopuncture is performed with a Nd:YAG laser on the trabecular meshwork. Four punctures are created along the 180° nasal trabecular meshwork.

Study summary

The purpose of this study is to perform trabeculopuncture a test to determine the distal outflow tract function to predict the success of ab interno trabeculectomy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * individuals ≥ 18 years of age * clinical diagnosis of: primary open angle glaucoma, pigmentary glaucoma, or pseudoexfoliation glaucoma * uncontrolled intraocular pressure (IOP) with maximally tolerated medical therapy * progressive thinning of retinal nerve fiber layer assessed by Spectral domain optical coherence tomography (p \< 0.05) * progression of visual field defects * visually significant cataract and indication to reduce IOP or glaucoma medication burden Exclusion Criteria: * clinical diagnosis of neovascular glaucoma, angle-closure glaucoma, uveitic glaucoma, neovascular glaucoma * prior glaucoma surgery * preexisting conditions affecting the episcleral venous pressure including Grave's ophthalmopathy, Sturge-Weber syndrome, Arteriovenous fistulas (carotid-cavernous fistula)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Uniklinikum Würzburg Würzburg Bavaria Recruiting

More Wuerzburg University Hospital trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06523751 on ClinicalTrials.gov ↗ ← All trials in Germany